ACT-Candesartan 4mg tablets (2018-11-23)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| K49247, K49268, K49269, K50970, K50973, K51008 | ACT-Candesartan 4mg tablets | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Tablets | DIN 02376520 | Candesartan Cilexetil 4mg |
Recalled Products
ACT-Candesartan 4mg tablets
An impurity out of specification is expected near the expiry date in the affected lots.